• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

五种欧洲国家肥胖的终生健康和经济负担:预防的潜在影响是什么?

The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention?

机构信息

Institute for Medical Technology Assessment (iMTA), Erasmus University Rotterdam, Rotterdam, the Netherlands.

Erasmus School of Health Policy & Management (ESHPM), Erasmus University Rotterdam, Rotterdam, the Netherlands.

出版信息

Diabetes Obes Metab. 2023 Aug;25(8):2351-2361. doi: 10.1111/dom.15116. Epub 2023 May 24.

DOI:10.1111/dom.15116
PMID:37222003
Abstract

AIM

Estimating the burden of obesity in five European countries (Germany, Greece, the Netherlands, Spain and the UK) and the potential health benefits and changes in health care costs associated with a reduction in body mass index (BMI).

MATERIALS AND METHODS

A Markov model was used to estimate the long-term burden of obesity. Health states were based on the occurrence of diabetes, ischaemic heart disease and stroke. Multiple registries and literature sources were used to derive the demographic, epidemiological and cost input parameters. For the base-case analyses, the model was run for a starting cohort of healthy obese people with a BMI of 30 and 35 kg/m aged 40 years to estimate the lifetime impact of obesity and the impact of a one-unit decrease in BMI. Different scenario and sensitivity analyses were performed.

RESULTS

The base-case analyses showed that total lifetime health care costs (for obese people aged 40 and BMI 35 kg/m ) ranged from €75 376 in Greece to €343 354 in the Netherlands, with life expectancies ranging from 37.9 years in Germany to 39.7 years in Spain. A one-unit decrease in BMI showed gains in life expectancy ranging from 0.65 to 0.68 year and changes in total health care costs varying from -€1563 to +€4832.

CONCLUSIONS

The economic burden of obesity is substantial in the five countries. Decreasing BMI results in health gains, reductions in obesity-related health care costs, but an increase in non-obesity related health care costs, which emphasizes the relevance of including all costs in decision making on implementation of preventive interventions.

摘要

目的

估计五个欧洲国家(德国、希腊、荷兰、西班牙和英国)的肥胖负担,以及与体重指数(BMI)降低相关的潜在健康益处和医疗保健成本变化。

材料和方法

使用马尔可夫模型来估计肥胖的长期负担。健康状况基于糖尿病、缺血性心脏病和中风的发生情况。多项登记处和文献来源用于获得人口统计学、流行病学和成本输入参数。对于基础案例分析,模型针对 BMI 为 30 和 35kg/m、年龄为 40 岁的健康肥胖人群进行了运行,以估计肥胖的终身影响以及 BMI 降低一个单位的影响。进行了不同的情景和敏感性分析。

结果

基础案例分析表明,总终身医疗保健成本(针对 40 岁和 BMI 为 35kg/m 的肥胖人群)范围从希腊的 75376 欧元到荷兰的 343354 欧元,预期寿命范围从德国的 37.9 年到西班牙的 39.7 年。BMI 降低一个单位可使预期寿命增加 0.65 至 0.68 年,总医疗保健成本变化从 -1563 欧元到+4832 欧元不等。

结论

在这五个国家,肥胖的经济负担是巨大的。降低 BMI 可带来健康收益,降低与肥胖相关的医疗保健成本,但会增加与非肥胖相关的医疗保健成本,这强调了在实施预防干预措施的决策中纳入所有成本的重要性。

相似文献

1
The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention?五种欧洲国家肥胖的终生健康和经济负担:预防的潜在影响是什么?
Diabetes Obes Metab. 2023 Aug;25(8):2351-2361. doi: 10.1111/dom.15116. Epub 2023 May 24.
2
Healthcare costs and obesity prevention: drug costs and other sector-specific consequences.医疗保健成本与肥胖预防:药品成本与其他特定部门的后果。
Pharmacoeconomics. 2009;27(12):1031-44. doi: 10.2165/11319900-000000000-00000.
3
The effectiveness of web-based programs on the reduction of childhood obesity in school-aged children: A systematic review.基于网络的项目对学龄儿童肥胖症减轻的有效性:一项系统评价。
JBI Libr Syst Rev. 2012;10(42 Suppl):1-14. doi: 10.11124/jbisrir-2012-248.
4
Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.美国国家菜单卡路里标签法的健康与经济影响:一项微观模拟研究
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006313. doi: 10.1161/CIRCOUTCOMES.119.006313. Epub 2020 Jun 4.
5
Long-term cost-effectiveness of interventions for obesity: A mendelian randomisation study.肥胖干预措施的长期成本效益:一项孟德尔随机化研究。
PLoS Med. 2021 Aug 27;18(8):e1003725. doi: 10.1371/journal.pmed.1003725. eCollection 2021 Aug.
6
The future burden of obesity-related diseases in the 53 WHO European-Region countries and the impact of effective interventions: a modelling study.世界卫生组织欧洲区域53个国家肥胖相关疾病的未来负担及有效干预措施的影响:一项建模研究
BMJ Open. 2014 Jul 25;4(7):e004787. doi: 10.1136/bmjopen-2014-004787.
7
Economic costs of adult obesity: a review of recent European studies with a focus on subgroup-specific costs.成人肥胖的经济成本:对近期欧洲研究的综述,重点关注特定亚组的成本。
Maturitas. 2011 Jul;69(3):220-9. doi: 10.1016/j.maturitas.2011.04.005. Epub 2011 May 18.
8
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
9
Economic burden of work injuries and diseases: a framework and application in five European Union countries.工作相关伤害和疾病的经济负担:一个框架及其在五个欧盟国家的应用。
BMC Public Health. 2021 Jan 6;21(1):49. doi: 10.1186/s12889-020-10050-7.
10
Lifetime health and economic consequences of obesity.肥胖对一生健康和经济的影响。
Arch Intern Med. 1999 Oct 11;159(18):2177-83. doi: 10.1001/archinte.159.18.2177.

引用本文的文献

1
The Economic Cost of Obesity: A Cost-of-Illness Study in Greece.肥胖的经济成本:希腊的疾病成本研究。
Appl Health Econ Health Policy. 2025 Aug 27. doi: 10.1007/s40258-025-01002-6.
2
Critical Analysis of Markov Modeling for the Economic Evaluation of Obesity Interventions: A Systematic Review.肥胖干预措施经济评估的马尔可夫模型批判性分析:一项系统综述
Risk Manag Healthc Policy. 2025 Jun 28;18:2169-2187. doi: 10.2147/RMHP.S528064. eCollection 2025.
3
Text messaging with or without financial incentives versus a waitlist control for weight loss in men: cost-effectiveness analysis of the Game of Stones randomised controlled trial.
有或无经济激励措施的短信干预与等待名单对照用于男性减肥:“石头游戏”随机对照试验的成本效益分析
Lancet Reg Health Eur. 2025 May 21;54:101328. doi: 10.1016/j.lanepe.2025.101328. eCollection 2025 Jul.
4
Cost-Effectiveness of Personalised Nutrition in Adults With Overweight and Obesity: PREVENTOMICS Studies in Poland and the UK.超重和肥胖成年人个性化营养的成本效益:波兰和英国的PREVENTOMICS研究
J Hum Nutr Diet. 2025 Jun;38(3):e70071. doi: 10.1111/jhn.70071.
5
Risk of severe obesity development: Examining the role of psychological well-being related measures and sociodemographic factors in two longitudinal UK cohort studies.严重肥胖症发展风险:在两项英国纵向队列研究中考察与心理健康相关的指标及社会人口学因素的作用
Br J Health Psychol. 2025 May;30(2):e12798. doi: 10.1111/bjhp.12798.
6
The first 1000 days: the price of inequalities in high and middle-income countries.最初的1000天:中高收入国家不平等现象的代价。
Pediatr Res. 2025 Jan 24. doi: 10.1038/s41390-025-03880-x.
7
Management of nutritional deficiencies following one anastomosis gastric bypass (OAGB): a single-center experience.单吻合口胃旁路术(OAGB)后营养缺乏的管理:单中心经验
Updates Surg. 2025 Jan 20. doi: 10.1007/s13304-025-02094-4.
8
The Impact of Economic Income on BMI Trajectory Groups in Chinese Elderly Individuals: A Population-Based Longitudinal Study.经济收入对中国老年人BMI轨迹组的影响:一项基于人群的纵向研究。
Nutrients. 2024 Dec 26;17(1):34. doi: 10.3390/nu17010034.
9
Body Composition Trend in Slovene Adults: A Two-Year Follow-Up.斯洛文尼亚成年人身体成分趋势:一项为期两年的随访研究
Nutrients. 2024 Nov 28;16(23):4123. doi: 10.3390/nu16234123.
10
A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.采用欧盟 HTA 核心模型对个性化营养干预措施进行卫生技术评估。
Int J Technol Assess Health Care. 2024 Mar 6;40(1):e15. doi: 10.1017/S0266462324000060.